Now more than ever, 30 million Americans living with a range of 7000 rare or orphan diseases require a high level of therapy adherence support.
Donovan Quill, President and CEO, Optime Care
Advertisement
Articles by Donovan Quill, President and CEO, Optime Care
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
2
Nicotine Pouches Create Opportunity for Pharmacist Counseling
3
FDA Approves Finerenone for Chronic Kidney Disease With Type 1 Diabetes
4
Scripted for Her: The Pharmacist's Role in HPV Prevention
5